Scanvio

Scanvio

AI-assisted ultrasound for early endometriosis diagnosis at initial gynecologic exams.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
*

CHF150k

Grant
Total Funding000k
More about Scanvio
Made with AI
Edit

Scanvio focuses on enhancing early diagnosis of endometriosis through AI-assisted ultrasound technology, targeting millions of women affected by this condition. The company operates in the healthcare sector, specifically within the gynecological diagnostics market. By integrating machine learning expertise with advanced ultrasound techniques, Scanvio aims to provide a more accurate and timely diagnosis during the first gynecologic examination. This approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with delayed diagnosis. The business model likely involves partnerships with healthcare providers and clinics, offering their technology as a service to improve diagnostic capabilities. Revenue generation may stem from licensing agreements or service fees for the use of their AI-driven diagnostic tools.

Keywords: endometriosis, AI, ultrasound, diagnosis, gynecology, healthcare, machine learning, women's health, early detection, medical technology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads